Researchers have shown that not only the ‘where’ and the ‘when’ of long non-coding RNA expression is important for their function, but also the ‘how’.
Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon.
China might be the frontrunners when it comes to medical advances, but questions surrounding their ethical lapses, hinders their successes.
Novartis’ entry into the digital technology market intensifies with the recent launch of its mobile-phone based app to help collect data from eye disease studies.
A debate at AACR raised the question of whether or not the idea of precision therapies targeting a patient’s cancer genome has been oversold,
E. coli bacteria are the frequent culprits behind outbreaks of food-borne illnesses. But not all strains are harmful; some are even helpful.
AI genomics company Freenome has announced a partnership with proteomics company Biognosys, to enhance its broad-signal approach to early-cancer detection and precision oncology.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
New method uses patients’ unique genetic variation profiles to aid in personalised medicine.
As a post-antibiotic future beckons, how can humanity protect itself against the proliferation of superbugs? Research suggests ‘drug sanctuaries’ in hospitals could be a promising solution.
Is peer review biased? Female health researchers who applied for grants from Canada’s major health research funder were funded less often than male counterparts because of potential bias, and characteristics of peer reviewers can also affect the result, a study has found.
It’s been a busy time for R&D execs, as they continue to be snapped up by rival pharma companies, proving that it’s a competitive time out there at the top.
Illumina’s new Bay Area campus boasts connectivity, collaboration, and innovation, but some are unsure whether it will be able to draw in the appeal from workers.
Human Cell Atlas researchers at the Broad Institute and the Wellcome Sanger Institute have released new datasets containing information on immune and stromal cells.
The gene atlas enables a new functional view on how we study the human genome, and provides a tool that will change how we study and treat cancer and genetic disorders.